Management of Relapsed/Refractory Multiple Myeloma
This information was originally presented on September 21, 2013, at the NCCN 8th Annual Congress: Hematologic Malignancies™ held in New York, New York.
This activity is designed to meet the educational needs of hematologists, oncologists, nurses, pharmacists, and other health care professionals who manage patients with hematologic malignancies.
Following this activity, participants should be able to:
- Identify the latest advances and current therapeutic strategies to optimize outcomes of patients with relapsed/refractory myeloma
Kenneth C. Anderson, MD
Dana-Farber/Brigham and Women's Cancer Center
- 0.50 Participation
- 0.43 Nurse
- 0.50 Pharmacist
- 0.50 Physician